Regdanvimab Uses, Dosage, Side Effects and more
Regdanvimab is under investigation in clinical trial NCT04593641 (This Is a Phase 1 Study to Evaluate the Safety,tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)).
| Trade Name | Regdanvimab |
| Generic | Regdanvimab |
| Regdanvimab Other Names | Regdanvimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
